Testing STIs to Improve PrEP Use in Pregnancy
Part of Infections clinical trials.
This trial tests whether STI testing during pregnancy helps more women start and stay on PrEP (a daily pill that prevents HIV). If you join, you'll help find better ways to protect both mother and baby from HIV.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and going for antenatal (pregnancy) care
- You are a cis-gender woman (you identify with the sex you were assigned at birth)
- You do not have HIV
- You are not currently taking PrEP (a daily HIV prevention pill)
- You plan to stay in this city or town for your pregnancy care and for 9 months after delivery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help women at risk for HIV stay healthy while planning or having children. It provides prevention tools and support to reduce the chance of getting HIV.
This study helps young people who are at risk for HIV get on PrEP—a daily pill or shot that prevents HIV. It tests different ways to help you start and stay on PrEP, with care available at clinics or in your community.
This study checks if routine testing for sexually transmitted infections (STIs) during early pregnancy can improve health for you and your baby. Participation involves a simple screening test at your first prenatal visit.
This study looks at how well a daily pill called PrEP can prevent HIV in pregnant women and their babies. It aims to make sure these women get the support they need to stay healthy.
This study tests if combining sexually transmitted infection (STI) testing with HIV prevention medication (PrEP) helps control the HIV epidemic. It is for sexually active women aged 15-39 who live in Rakai and recently participated in a community health survey.
This study looks at making it easier for young women to get STI and HIV prevention services like PrEP (a daily pill to prevent HIV) when they pick up birth control at a retail pharmacy. It aims to see if offering these services in a pharmacy setting helps women access prevention more easily.
Hear when a new PrEP Adherence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.